Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Analysis of Prostate Cancer R' returned 451 results - Page 1 of 23  FEATURED RESULTS Drug Delivery in Cancer - Technologies, Markets and Companies Cancer Diagnostic Testing World Markets Antibody Drug Target Atlas in Oncology DNA Repair in Cancer Therapy. Molecular Targets and Clinical... Cancer Diagnostic Testing World Markets   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Global Prostate Cancer Therapeutics Market (2010 – 2020) (Opportunity Analysis, Pipeline Assessment & Market Forecast)   Markets and Markets, Nov 2011, Pages: 286 For Prostate Cancer Treatment Table 101 Astrazeneca Plc: Revenue And R&D Expenses, 2008 - 2010 ($Million) Table 102 Astrazeneca Plc: Revenue, By Business Segments, 2008 - 2010 ($Million) Table 103 Astrazeneca A Decision Support Tool for Optimizing the Prostate Cancer Pipeline: From Research and Development to Market   Bioseeker, June 2010, Pages: 838 6.6 The Drug-Target Interactome 6.7 Protein Expression Levels of Identified Targets of Prostate Cancer Drugs 6.8 Pathway Assessment of Prostate Cancer Therapeutic Targets 6.8.1 Tools for Analysis Analytical Tool - Prostate Cancer   Bioseeker, Feb 2011 Research and Development to Market Prostate Cancer Drug Pipeline Update 2011-. The Package Includes - A progress analysis on current and emerging drugs - Information on most companies active in prostate cancer R Biomarkers - Technologies, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 864 intraepithelial neoplasia Epigenetic biomarkers of prostate cancer Gene expression analysis of prostate cancer Genetic biomarkers of prostate cancer Huntingtin Interacting Protein 1 overexpression in prostate Triple Analysis: Lung Cancer, Prostate Cancer and Cancer Vaccines   Bioseeker, July 2011, Pages: 2820 This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Prostate Cancer and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts Currently Druggable in Prostate Cancer: A Drug Target Competitive Analysis   Bioseeker, Sep 2008, Pages: 306 combination breakdown of prostate cancer drugs into R&D approaches - Unique drug-protein target interactome- and protein-protein interactome of drug targets analysis - Pathway profiling of prostate cancer Triple Analysis: Breast Cancer, Prostate Cancer and Cancer Vaccines   Bioseeker, Oct 2010, Pages: 2410 This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Prostate Cancer and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual Triple Analysis: Colorectal Cancer, Prostate Cancer and Cancer Vaccines   Bioseeker, March 2011, Pages: 2553 This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Prostate Cancer and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual Prostate Cancer Minimally Invasive Surgery Market in North America and Europe (2011 - 2016)   Transparency Market Research, Nov 2011, Pages: 83 INVASIVE PROSTATE CANCER SURGERY MARKET, BY DEVICES (USD MILLION) TABLE 25 ANGIODYNAMICS, INC. TOTAL REVENUES AND R&D EXPENSES (USD THOUSAND) TABLE 26 ANGIODYNAMICS, INC. BUSINESS SEGMENT REVENUE (USD Triple Analysis: Pancreatic Cancer, Prostate Cancer and Cancer Vaccines   Bioseeker, Oct 2010, Pages: 2107 This triple analysis focuses on cancer drug development strategies in both Pancreatic Cancer and Prostate Cancer and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual Triple Analysis: Breast Cancer, Lung Cancer and Prostate Cancer   Bioseeker, July 2011, Pages: 3074 This triple analysis focuses on cancer drug development strategies in Breast Cancer, Lung Cancer and Prostate Cancer. Each of these three individual parts is evaluated according to standardized Triple Analysis: Colorectal Cancer, Lung Cancer and Prostate Cancer   Bioseeker, July 2011, Pages: 3217 This triple analysis focuses on cancer drug development strategies in Colorectal Cancer, Lung Cancer and Prostate Cancer. Each of these three individual parts is evaluated according to standardized Triple Analysis: Lung Cancer, Pancreatic Cancer and Prostate Cancer   Bioseeker, July 2011, Pages: 2771 This triple analysis focuses on cancer drug development strategies in Lung Cancer, Pancreatic Cancer and Prostate Cancer. Each of these three individual parts is evaluated according to standardized Triple Analysis: Breast Cancer, Colorectal Cancer and Prostate Cancer   Bioseeker, March 2011, Pages: 2807 This triple analysis focuses on cancer drug development strategies in Breast Cancer, Colorectal Cancer and Prostate Cancer. Each of these three individual parts is evaluated according Triple Analysis: Breast Cancer, Pancreatic Cancer and Prostate Cancer   Bioseeker, May 2010, Pages: 2361 This triple analysis focuses on cancer drug development strategies in Breast Cancer, Pancreatic Cancer and Prostate Cancer. Each of these three individual parts is evaluated according Triple Analysis: Colorectal Cancer, Pancreatic Cancer and Prostate Cancer   Bioseeker, March 2011, Pages: 2504 This triple analysis focuses on cancer drug development strategies in Colorectal Cancer, Pancreatic Cancer and Prostate Cancer. Each of these three individual parts is evaluated according Oncology Therapeutics Market to 2017 - High Unmet Need in the Management and Treatment of Metastatic Cancers to Drive Drug Development   GBI Research, Dec 2011, Pages: 215 . The report provides an in-depth analysis of major oncology indications, which includes breast cancer, colorectal cancer, Non-Hodgkin’s Lymphoma (NHL), Non-Small Cell Lung Cancer (NSCLC), prostate cancer Triple Analysis: Prostate Cancer, Cancer Vaccines and Antibodies   Bioseeker, Sep 2011, Pages: 3441 This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Prostate Cancer), one mechanism/target/effect area (Cancer Vaccines) and one compound specific Triple Analysis: Prostate Cancer, Cancer Vaccines and Protein Kinase Inhibitors   Bioseeker, Oct 2010, Pages: 2939 This triple analysis focuses on cancer drug development strategies in Prostate Cancer and by the two mechanism/target/effect areas of Cancer Vaccines and Protein Kinase Inhibitors. Each Triple Analysis: Prostate Cancer, Cancer Vaccines and Peptides   Bioseeker, Nov 2011, Pages: 2403 This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Prostate Cancer), one mechanism/target/effect area (Cancer Vaccines) and one compound specific Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network